Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Seminars in Cancer Biology
|
August 22, 2018
Pancreatic cancer stem cells: A state or an entity?
Patrick C Hermann, Bruno Sainz
Clinical Chemistry
|
January 5, 2013
Metastatic cancer stem cells--quo vadis?
Patrick C Hermann, Christopher Heeschen
Molecular Oncology
|
June 29, 2010
Pancreatic cancer stem cells - update and future perspectives
Enza Lonardo, Patrick C Hermann, Christopher Heeschen
Journal of Leukocyte Biology
|
March 12, 2016
Proteolytic processing of human serum albumin generates EPI-X4, an endogenous antagonist of CXCR4
Onofrio Zirafi, Patrick C Hermann, Jan Münch
Frontiers in Bioscience (Elite Edition)
|
December 29, 2009
Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis
Maria-Theresa Mueller, Patrick C Hermann, Christopher Heeschen
Cell Cycle (Georgetown, Tex.)
|
February 8, 2008
Metastatic cancer stem cells: a new target for anti-cancer therapy?
Patrick C Hermann, Stephan L Huber, Christopher Heeschen
Expert Opinion on Biological Therapy
|
September 3, 2009
Pancreatic cancer stem cells--insights and perspectives
Patrick C Hermann, Maria-Theresa Mueller, Christopher Heeschen
Seminars in Cancer Biology
|
April 8, 2010
Cancer stem cells in solid tumors
Patrick C Hermann, Sonu Bhaskar, Michele Cioffi, et al.
Cell Cycle (Georgetown, Tex.)
|
March 17, 2012
Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness
Enza Lonardo, Javier Frias-Aldeguer, Patrick C Hermann, et al.
Cancers
|
August 11, 2019
EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells
Eva Rodriguez-Aznar, Lisa Wiesmüller, Bruno Sainz, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Seminars in Cancer Biology
|
August 22, 2018
Pancreatic cancer stem cells: A state or an entity?
Patrick C Hermann, Bruno Sainz
Clinical Chemistry
|
January 5, 2013
Metastatic cancer stem cells--quo vadis?
Patrick C Hermann, Christopher Heeschen
Molecular Oncology
|
June 29, 2010
Pancreatic cancer stem cells - update and future perspectives
Enza Lonardo, Patrick C Hermann, Christopher Heeschen
Journal of Leukocyte Biology
|
March 12, 2016
Proteolytic processing of human serum albumin generates EPI-X4, an endogenous antagonist of CXCR4
Onofrio Zirafi, Patrick C Hermann, Jan Münch
Frontiers in Bioscience (Elite Edition)
|
December 29, 2009
Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis
Maria-Theresa Mueller, Patrick C Hermann, Christopher Heeschen
Cell Cycle (Georgetown, Tex.)
|
February 8, 2008
Metastatic cancer stem cells: a new target for anti-cancer therapy?
Patrick C Hermann, Stephan L Huber, Christopher Heeschen
Expert Opinion on Biological Therapy
|
September 3, 2009
Pancreatic cancer stem cells--insights and perspectives
Patrick C Hermann, Maria-Theresa Mueller, Christopher Heeschen
Seminars in Cancer Biology
|
April 8, 2010
Cancer stem cells in solid tumors
Patrick C Hermann, Sonu Bhaskar, Michele Cioffi, et al.
Cell Cycle (Georgetown, Tex.)
|
March 17, 2012
Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness
Enza Lonardo, Javier Frias-Aldeguer, Patrick C Hermann, et al.
Cancers
|
August 11, 2019
EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells
Eva Rodriguez-Aznar, Lisa Wiesmüller, Bruno Sainz, et al.
Page
of 5